Active Ingredient(s): Urofollitropin, FSH
FDA Approved: * May 6, 2002
Pharm Company: * FERRING
Category: Women's Health / Fertility

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Bravelle Overview

Urofollitropin is a purified form of follicle-stimulating hormone (FSH) that is manufactured by extraction from human urine and then purified[1] to remove various proteins and other substances. FSH is important in the development of follicles (eggs) produced by the ovaries. Given by subcutaneous injection, it is used in combination with human chorionic gonadotropin (hCG) to assist in ovulation and fertility.[2] It is also used with in vitro fertilization method...

Read more Bravelle Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Bravelle Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Urofollitropin, FSH
  • Injection: 0.9%, 0.90%, 150 iu/amp, 75 iu/amp, 75 iu/vial, 75IU, 75IU/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Bravelle: (1 result)

Sorted by National Drug Code
  • 55566-8505 Bravelle Subcutaneous Kit by Ferring Pharmaceuticals Inc.

Other drugs which contain Urofollitropin, FSH or a similar ingredient: (2 results)